摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,5R)-(2,2-dimethyl-5-propyl-1,3-dioxolan-4-yl)methanol | 160549-92-8

中文名称
——
中文别名
——
英文名称
(4R,5R)-(2,2-dimethyl-5-propyl-1,3-dioxolan-4-yl)methanol
英文别名
(4R, 5R)-(2,2-Dimethyl-5-propyl-1,3-dioxolan-4-yl)methanol;[(4R,5R)-2,2-dimethyl-5-propyl-1,3-dioxolan-4-yl]methanol
(4R,5R)-(2,2-dimethyl-5-propyl-1,3-dioxolan-4-yl)methanol化学式
CAS
160549-92-8
化学式
C9H18O3
mdl
——
分子量
174.24
InChiKey
BIWWKAWWWUHFRE-HTQZYQBOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Mixtures and compositions suitable for controlling Hylotrupes bajulus and Pyrrhidium sanguineum
    申请人:BASF Aktiengesellschaft
    公开号:US06245328B1
    公开(公告)日:2001-06-12
    A mixture containing one stereoisomer of 3-hydroxyhexan-2-one and two stereoisomers of hexane-2,3-diol, especially (3R)-3-hydroxy-hexan-2-one, (2R,3R)-hexane-2,3-diol and/or (2R,3R)-hexane-2,3-diol and compositions containing them and the use of the mixture and of the compositions for controlling Hylotrupes bajulus and Pyrrhidium sanguineum by means of the monitoring, capture or mating disruption method are described.
    本文描述了一种混合物,其中包含3-羟基己酮的一个立体异构体和两个己二醇的立体异构体,特别是(3R)-3-羟基-己酮,(2R,3R)-己二醇和/或(2R,3R)-己二醇以及含有它们的组合物,并且利用该混合物和组合物通过监测、捕获或交配干扰方法控制松墨天牛和红天牛的使用。
  • Divergent synthesis of (6S,1′S,2′R)-hydroxypestalotin via tandem conjugate addition–lactonization sequence
    作者:Venkata Satyanarayana Mallula、Batthula Srinivas、Palakodety Radha Krishna
    DOI:10.1016/j.tetlet.2015.01.069
    日期:2015.2
    The stereoselective synthesis of (65,1'S,2'R)-hydroxypestalotin from trans-hex-2-en-1-ol utilizing asymmetric dihydroxylation and Luche's reduction and tandem conjugative addition-lactonization as the key steps is reported. (C) 2015 Elsevier Ltd. All rights reserved.
  • US6245328B1
    申请人:——
    公开号:US6245328B1
    公开(公告)日:2001-06-12
  • [EN] ORGANIC COMPOUNDS<br/>[FR] COMPOSÉS ORGANIQUES
    申请人:BARRY CLIFTON
    公开号:WO2011087995A2
    公开(公告)日:2011-07-21
    This invention provides compounds which are useful in the treatment of mycobacterial infections, pharmaceutical compositions containing the compounds, processes for their preparation, and uses of the compounds in various medicinal applications, such as the treatment or prevention of mycobacterial infections, such as those caused by Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium leprae, Mycobacterium africanum, Mycobacterium avium, Mycobacterium microti, or any mycobacterium that causes multi-drug resistant (MDR) TB or extensively resistant (XDR) TB, or any other mycobacterial species known to cause disease in humans; or the treatment or prevention of parasitic diseases, such as those caused by a parasite of the genus Trypanosoma, e.g. Trypanosoma cruzi or Trypanosoma brucei or a parasite of the genus Leishmania which causes visceral leishmaniasis or kala-azar, e.g., Leishmania donovani.
  • Schroeder, Frank; Fettkoether, Regina; Noldt, Uwe, Liebigs Annalen der Chemie, 1994, # 12, p. 1211 - 1218
    作者:Schroeder, Frank、Fettkoether, Regina、Noldt, Uwe、Dettner, Konrad、Koenig, Wilfried A.、Francke, Wittko
    DOI:——
    日期:——
查看更多